Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - NERIUM BIOTECHNOLOGY INC | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - NERIUM BIOTECHNOLOGY INC | ex31_2.htm |
| EX-32.1 - EXHIBIT 32.1 - NERIUM BIOTECHNOLOGY INC | ex32_1.htm |
| 10-K - NERIUM BIOTECHNOLOGY, INC 10-K 12-31-2011 - NERIUM BIOTECHNOLOGY INC | form10k.htm |
EXHIBIT 32.2
SARBANES-OXLEY SECTION 906 CERTIFICATION
In connection with the Annual Report of Nerium Biotechnology, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph B. Nester, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Joseph B. Nester
|
|
|
Joseph B. Nester
|
|
|
Chief Financial Officer
|
|
|
|
|
|
March 28, 2012
|
|